BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36994643)

  • 1. Long-term results of liver thermal ablation in patients with hepatocellular carcinoma and colorectal cancer liver metastasis regarding spatial features and tumor-specific variables.
    Akhan O; Erdemir AG; Karahan S; Ünal E; Çiftçi TT; Akıncı D; Yalçın Ş
    Diagn Interv Radiol; 2024 May; 30(3):183-192. PubMed ID: 36994643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?
    Li Z; Wang C; Li J; Liu Z; Jiao D; Han X
    BMC Cancer; 2021 May; 21(1):562. PubMed ID: 34001036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.
    Lee DH; Lee JM; Lee JY; Kim SH; Yoon JH; Kim YJ; Han JK; Choi BI
    Radiology; 2014 Mar; 270(3):900-9. PubMed ID: 24475823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance.
    Peng S; Huang P; Yu H; Wen Y; Luo Y; Wang X; Zhou J; Qin S; Li T; Chen Y; Liu G; Huang M
    Medicine (Baltimore); 2018 Mar; 97(10):e0044. PubMed ID: 29517661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application.
    An C; Li X; Zhang M; Yang J; Cheng Z; Yu X; Han Z; Liu F; Dong L; Yu J; Liang P
    BMC Cancer; 2020 Jan; 20(1):44. PubMed ID: 31959147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAGES/AHPBA guidelines for the use of microwave and radiofrequency liver ablation for the surgical treatment of hepatocellular carcinoma or colorectal liver metastases less than 5 cm.
    Ceppa EP; Collings AT; Abdalla M; Onkendi E; Nelson DW; Ozair A; Miraflor E; Rahman F; Whiteside J; Shah MM; Ayloo S; Dirks R; Kumar SS; Ansari MT; Sucandy I; Ali K; Douglas S; Polanco PM; Vreeland TJ; Buell J; Abou-Setta AM; Awad Z; Kwon CH; Martinie JB; Sbrana F; Pryor A; Slater BJ; Richardson W; Jeyarajah R; Alseidi A
    Surg Endosc; 2023 Dec; 37(12):8991-9000. PubMed ID: 37957297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.
    An C; Wu S; Huang Z; Ni J; Zuo M; Gu Y; Zhang T; Huang J
    Cancer Med; 2020 Jan; 9(1):104-115. PubMed ID: 31714685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
    Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
    Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice.
    Chinnaratha MA; Sathananthan D; Pateria P; Tse E; MacQuillan G; Mosel L; Pathi R; Madigan D; Wigg AJ
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):349-54. PubMed ID: 25563141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
    Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes following microwave ablation for liver malignancies.
    Leung U; Kuk D; D'Angelica MI; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; Fong Y
    Br J Surg; 2015 Jan; 102(1):85-91. PubMed ID: 25296639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis.
    Heerink WJ; Solouki AM; Vliegenthart R; Ruiter SJS; Sieders E; Oudkerk M; de Jong KP
    Eur Radiol; 2018 Aug; 28(8):3228-3236. PubMed ID: 29536242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical approach to microwave and radiofrequency liver ablation for hepatocellular carcinoma and colorectal liver metastases less than 5 cm: a systematic review and meta-analysis.
    Abdalla M; Collings AT; Dirks R; Onkendi E; Nelson D; Ozair A; Miraflor E; Rahman F; Whiteside J; Shah MM; Ayloo S; Abou-Setta A; Sucandy I; Kchaou A; Douglas S; Polanco P; Vreeland T; Buell J; Ansari MT; Pryor AD; Slater BJ; Awad Z; Richardson W; Alseidi A; Jeyarajah DR; Ceppa E
    Surg Endosc; 2023 May; 37(5):3340-3353. PubMed ID: 36542137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
    Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
    Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of combined radiofrequency ablation and multipronged ethanol ablation for the treatment of unfavorable hepatocellular carcinoma.
    Liu M; Li XJ; Zhang XE; Kuang M; Xie XY; Huang GL
    Diagn Interv Radiol; 2023 Mar; 29(2):342-349. PubMed ID: 36987999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.
    Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
    Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
    World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
    Puijk RS; Ruarus AH; Vroomen LGPH; van Tilborg AAJM; Scheffer HJ; Nielsen K; de Jong MC; de Vries JJJ; Zonderhuis BM; Eker HH; Kazemier G; Verheul H; van der Meijs BB; van Dam L; Sorgedrager N; Coupé VMH; van den Tol PMP; Meijerink MR;
    BMC Cancer; 2018 Aug; 18(1):821. PubMed ID: 30111304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
    Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
    BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.